Strong Americas and APMEA growth offset subdued European market conditions.
The new centre, located within Kerry’s existing Medellín campus, provides a dedicated environment for customers and strategic partners to move rapidly from concept ideation to testing and prototyping, shortening development cycles for food and beverage solutions.
The agreement represents a significant milestone in Kerry’s continued growth across the Middle East and underscores the company’s commitment to driving food and beverage innovation in one of the world’s most dynamic markets.
Biotechnology solutions present a new horizon of innovation and opportunity for global food, beverage and pharmaceutical markets.
These leadership changes come as part of the company’s strategic effort to strengthen its presence and operational excellence across key markets.